Providers can continue treating uninsured patients with the monoclonal antibody bebtelovimab after the product went on the commercial market last week because of a plan implemented by the North Carolina Department of Health and Human Services.
North Carolina Department of Health and Human Services Secretary Kody H. Kinsley and State Health Director and Chief Medical Officer Elizabeth Cuervo Tilson, M.D., MPH, today spoke with North Carolina’s county and local health directors.